NXTM Financial Facts
Provision for income taxes: 324KNet loss: -166K
See Full Income Statement
Accrued expenses: 29.34M
Accumulated deficit: -406M
See Full Balance Sheet
Nxstage Medical, Inc. (NXTM) Earnings
|
Expand Research on NXTM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +31.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/10  |
Q310 | -$0.17 | -$0.16 | -$0.01 | N/A | N/A | N/A |  | | Details | |
| 2/17/11 |
 |
Q410 | -$0.13 | -$0.14 | +$0.01 | $49.8M | $46.98M | = | | | Details |
| 5/4/11 |
|
Q111 | -$0.11 | -$0.12 | +$0.01 | $50.6M | $48.97M | = | | | Details |
| 8/3/11 |
|
Q211 | -$0.10 | -$0.11 | +$0.01 | $53.8M | $50.91M | = | | | Details |
| 11/3/11 |
|
Q311 | -$0.10 | -$0.10 | $0.00 | $55.9M | $53.87M | = | | | Details |
| 2/29/12 |
|
Q411 | $0.00 | -$0.09 | +$0.09 | $57M | $56.21M | = | | | Details |
| 5/8/12 |
|
Q112 | -$0.09 | -$0.10 | +$0.01 | $57M | $56.47M | = | | | Details |
| 8/8/12 |
|
Q212 | -$0.09 | -$0.10 | +$0.01 | $59M | $58.22M | = | | | Details |
